Characteristics of consumers of hypoglycemic drugs within the framework of preferential drug provision, using the example of the Stavropol Territory

The aim. To study the main characteristics of consumers of hypoglycemic drugs (HGD) within the framework of preferential drug provision (PDP) in the Stavropol Territory (ST). 

Materials and methods. The study was based on depersonalized information about patients with diabetes mellitus (DM) from the database of clinical and epidemiological monitoring of DM and data from the Regional Endocrinological Dispensary. Methods of comparative, retrospective, graphical analyses, grouping, and determination of average values were used.

Results. Among the beneficiaries with DM in the ST, individuals with type II DM prevail. In the type I DM group, men predominate (over 55.0%), while among patients with type II DM, women predominate (65.0%). The largest proportion among beneficiaries with type I DM is occupied by individuals from 30 to 60 years old, with type II DM, individuals aged 60 to 80 years predominate (70.44% — 2025). The increase in the number of beneficiaries with a disease duration of up to 5 years and over 10 years was noted. The life expectancy of beneficiaries with type I DM tends to increase slightly but steadily, while for patients with type II DM, it remains practically unchanged. A positive trend was noted in achieving the norm of glycated hemoglobin (HbA_1c) in beneficiaries with type I DM, and for every third patient with type II DM. For every third beneficiary with type I DM and for 70.0% with type II DM, body mass index (BMI) values are above normal. The structure of HGD consumption was determined, and changes in the ratio of the use of groups of oral HGD and individual trade names of drugs were revealed.

Conclusion. The general characteristics of beneficiaries with DM were identified, depending on its type, age and sex composition, duration of the disease, life expectancy, achievement of glycated hemoglobin levels, BMI, and the use of drugs in therapy.

1. Dubrovin MS, Polunin VS. The medical social portrait of patient with maxillofacial trauma. Russian Medicine. 2013;19(3):9–11. DOI: 10.17816/rmj38054

2. Biryukov VV, Breusov AV, Fomina AV, Plyaskina US. Problem Issues In Organizing Medical Care For Patients With Diabetic Retinopathy (Literature Review). Modern problems of healthcare and medical statistics. 2024;(5):649–667. DOI: 10.24412/2312-2935-2024-5-649-667 EDN: CIHXQW

3. Larina VN, Kudina EV, Shcherbina ES, Mikhailusova MP, Orlov DA. Kladovikova O.V. Clinical portrait of elderly outpatient. Therapy. 2024;10(3(75)):41–51. DOI: 10.18565/therapy.2024.3.41-51 EDN: KZHASC

4. Moor LV, Rakhmazova LD. A Social and demographic profile of inpatient cohort of subjects with anxiety-phobic disorders. Modern problems of science and education. 2018;(5):64. EDN: YMRKUH

5. Petrov DS, Konovalov OE, Shustov DI. medical and social characteristics of day hospital patients in psychoneurological dispensary and commercial medical center. Journal "Bulletin of Neurology, Psychiatry and Neurosurgery". 2019;(9):43–48. EDN: WNJAZD

6. Zubko AV, Sabgayda TP, Zemlyanova EV, Filatova AG, Kakuchaya TT, Zaporozhchenko VG, Polesskii VA. Social portrait of patients of the cardio-rehabilitation unit of a large cardio-surgical center. Health care of the Russian Federation. 2020;64(3):124–131. DOI: 10.46563/0044-197X-2020-64-3-124-131

7. Ketsko VA, Metelsky SM, Shpak PA. "Portrait" of an outpatient patient with bronchial asthma // Military medicine. 2022;(3(64)):114–116. EDN: LJSHNI

8. Balasaniantc GS, Bozhkov IA, Buchkina NN, Gutkin MG, Derevyanko AV, Zaitsev AV, Novizkya IN, Sinizyn AV, Shchedrina SV. Social profile of tuberculosis in urban area. Kuban Scientific Medical Bulletin. 2020;27(6):94-108. DOI: 10.25207/1608-6228-2020-27-6-94-108

9. Khalova KV. Social portrait of an orthopedic patient. Young scientist. 2015;(5(85)):93–96. EDN: TKLBWB

10. Rostova NB, Ivanova ES, Ivanova JN, Kiseleva OV. Portrait Of The Patient As A Basis For The Developmentof Proposals For Optimization Of Drug Therapy For HIV Infection. Siberian Medical Journal. 2015;134(3):87–91. EDN: UZOZRN

11. Mkrtumyan AM. Medical and social portrait of a patient with newly diagnosed diabetes mellitus on the example of the selection of participants in a clinical study of the treatment of impaired glucose tolerance. Effective pharmacotherapy. 2023;19(21):8–14. DOI: 10.33978/2307-3586-2023-19-21-8-14 EDN: LNYGEC

12. Sаgitova GR, Nuradenov XP, Еleseev FI. Medico-social portrait of a minor patient in modern conditions. Fundamental research. 2014;(2):156–158. EDN: RZQTUH

13. Zapariy NS, Asriyan YuA, Letskaya OA, Begma IV, Kuzina IV. Characteristics of the general contingent of disabled people due to diabetes mellitus among the adult population for the period 2017–2021. Bulletin of the Russian Society of Professionals in Medical and Social Expertise, Rehabilitation and Rehabilitational Industry. 2023;(3): 48–55. DOI: 10.17238/issn1999-2351.2023.3.48-55 EDN: JMCJEK

14. Rodionova AY, Stolov SV, Makarova OV. Clinical and expert characteristics of diabetic patients examined at the Bureau of medical and Social expertise. Botkin readings: Collection of abstracts of the All-Russian Therapeutic Congress with international participation, St. Petersburg, April 20-21, 2023; St. Petersburg: St. Petersburg Public Organization "Man and his Health"; 2023. P. 224–225. EDN: RDHNGC. Russian

15. Dymochka MA, Smirnova YuA, Verigina NB. Results of re-certification of children with disabilities due to diabetes mellitus, including after reaching the age of 18 years. Medical-Social Problems of Disability. 2023;(3):7–17. EDN: ALBNVI

16. Chikinova LN, Begma IV, Zapariy NS, Boltenko ZV. Comprehensive study of disability due to diabetes mellitus in the Russian Federation. Medical and Social Expert Evaluation and Rehabilitation. 2018;21(1-2):55–59. DOI: 10.18821/1560-9537-2018-21-1-55-59

17. Dedov II, Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA, Sazonova DV, Mokrysheva NG. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the Federal Register of Diabetes Mellitus for the period 2010–2022. Diabetes mellitus. 2023;26(2):104–123. DOI: 10.14341/DM13035

18. Biryukov VV, Breusov AV. Social portrait of the main contingent of patients with diabetes mellitus. Current problems of health care and medical statistics. 2025;(1):735–747. DOI: 10.24412/2312-2935-2025-1-735-747 EDN: UWXVKK

19. Lev IV. Biological age as a new risk factor for ophthalmic complications in type 2 diabetes mellitus. Current problems of health care and medical statistics. 2023;(2):311–322. DOI: 10.24412/2312-2935-2023-2-311-322 EDN: GJWEFZ

20. Kudryashov EA, Skibitsky VV, Zabolotskikh TB, Kudryashova YA. Сlinical portrait of the ambulatory patient with diabetes 2 types. South Russian Journal of Therapeutic Practice. 2022;3(3):50–59. DOI: 10.21886/2712-8156-2022-3-3-50-59

21. Gilmanshin TR, Kudasheva ZA, Nikitina AF, Imaeva AR, Startseva ASh. Some aspects of the medical and social status of patients with diabetic retinopathy. Point of View. East–West. 2025;12(2):31–36. DOI: 10.25276/2410-1257-2025-2-31-36 EDN: GCSUMT

22. Kitanina KY, Hromushin VA, Naumova EM, Zherebcova VA. Review of the methods of analysis of average life period of living in the assessment of health of population and effectiveness of recovery medicine methods. Clinical Medicine and Pharmacology. 2018;(4):39–48. DOI: 10.12737/article_5a72e5f604d182.97834573

23. Dedov I, Shestakova M, Mayorov A, Mokrysheva N, Andreeva E, Bezlepkina O, Peterkova V, Artemova E, Bardiugov P, Beshlieva D, Bondarenko O, Burumkulova F, Vikulova O, Volevodz N, Galstyan G, Gomova I, Grigoryan O, Dzhemilova Z, Ibragimova L, Kalashnikov V, Kononenko I, Kuraeva T, Laptev D, Lipatov D, Melnikova O, Mikhina M, Michurova M, Motovilin O, Nikonova T, Rozhivanov R, Smirnova O, Starostina E, Surkova E, Sukhareva O, Tiselko A, Tokmakova A, Shamkhalova M, Shestakova E, Jarek-Martynowa I, Yaroslavceva M Standards of Specialized Diabetes Care / Edited by Dedov II, Shestakova MV, Mayorov AYu. 11th Edition. Diabetes mellitus. 2023;26(2S):1–157. DOI: 10.14341/DM13042

24. Seidinova ASh, Abylayuly Zh. Does themethod of insulintherapy affect the body mass index in patients with diabetes mellitus? VESTNIK KAZNMU. 2019;(1):342–345. EDN: EGFYXH

25. Samorodskaya IV. Body mass index and the obesity paradox. RMJ. 2014;22(2):170–175. EDN: SKBPEB. Russian

26. Dedov II, Shestakova MV, Vikulova OK, Zheleznyakova AV, Isakov MA, Kutakova DV, Mokrysheva NG. Epidemiology and key clinical and therapeutic indicators of diabetes mellitus in Russian Federation according to the World Health Organization's strategy goals. Diabetes mellitus. 2025;28(1):4–17. DOI: 10.14341/DM13292

27. Klimontov VV, Yushin AYu, Semenova YuF, Korbut AI, Romanov VV. Overweight and obesity in patients with type 1 diabetes: associations with vascular complications and biomarkers of vascular remodeling. Diabetes mellitus. 2024;27(6):528–535. DOI: 10.14341/DM13209

28. Shukohifar M, Mozafari Z, Rahmanian M, Mirzaei M. Performance of body mass index and body fat percentage in predicting metabolic syndrome risk factors in diabetic patients of Yazd, Iran. BMC Endocr Disord. 2022 Aug 31;22(1):216. doi: 10.1186/s12902-022-01125-0

29. Yagudina RI, Listova OL. Analysis of preferential drug provision for patients with diabetes mellitus in the Stavropol Region. Pharmacy & Pharmacology. 2025;13(5):403–414. DOI: 10.19163/2307-9266-2025-13-5-403-414

30. Sorokina Ju, Monakhov A, Beresneva T. Rational combined pharmacotherapy under the type 2 diabetes mellitus: from insulin to gliptins. Universum: medicine and pharmacology. 2018;(4(49)):11–18. EDN: YVGVHM

31. Kosiborod MN, Petrie MC, Borlaug BA, Butler J, Davies MJ, Hovingh GK, Kitzman DW, Møller DV, Treppendahl MB, Verma S, Jensen TJ, Liisberg K, Lindegaard ML, Abhayaratna W, Ahmed FZ, Ben-Gal T, Chopra V, Ezekowitz JA, Fu M, Ito H, Lelonek M, Melenovský V, Merkely B, Núñez J, Perna E, Schou M, Senni M, Sharma K, van der Meer P, Von Lewinski D, Wolf D, Shah SJ; STEP-HFpEF DM Trial Committees and Investigators. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes. N Engl J Med. 2024;390(15):1394–1407. DOI: 10.1056/NEJMoa2313917

32. Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, Mathieu C, Pedersen SD, Davies M. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023;402(10403):720–730. DOI: 10.1016/S0140-6736(23)01163-7

33. Clements JM, Rosca M, Cavallin C, Falkenhagen S, Ittoop T, Jung CK, Mazzella M, Reed JA, Schluentz M, VanDyke C. Type 2 Diabetes and Chronic Conditions Disparities in Medicare Beneficiaries in the State of Michigan. Am J Med Sci. 2020;359(4):218–225. DOI: 10.1016/j.amjms.2020.01.013

34. Emerging Risk Factors Collaboration. Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation. Lancet Diabetes Endocrinol. 2023;11(10):731–742. DOI: 10.1016/S2213-8587(23)00223-1

35. Chu C, Zhang Y, Deng F, Zhang L. Long-term time in target range for body mass index (BMI) and diabetes incidence: insights from CHARLS. Nutr Diabetes. 2025;15(1):46. DOI: 10.1038/s41387-025-00404-8

36. Deng L, Jia L, Wu XL, Cheng M. Association Between Body Mass Index and Glycemic Control in Type 2 Diabetes Mellitus: A Cross-Sectional Study. Diabetes Metab Syndr Obes. 2025;18:555–563. DOI: 10.2147/DMSO.S508365

37. Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, Ling Lim GP, Rong Tay NW, Annan NC, Bhattamisra SK, Candasamy M. Type 1 and 2 diabetes mellitus: A review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr. 2019;13(1):364–372. DOI: 10.1016/j.dsx.2018.10.008

38. Araki A. Individualized treatment of diabetes mellitus in older adults. Geriatr Gerontol Int. 2024;24(12):1257–1268. DOI: 10.1111/ggi.14979